Trials / Completed
CompletedNCT06876727
Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair
A Target Trial Emulation for Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,325 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was a target trial emulation using the National Health Claims database established by the Korean National Health Insurance Service (K-NHIS). 8,325 patients were included.
Detailed description
Among these patients, any patients who were prescribed SAPT or DAPT at the date of discharge from the index hospitalization for standard EVAR were defined as being in the SAPT group (N=4,162) and the DAPT group (N=4,163), respectively.
Conditions
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
- First posted
- 2025-03-14
- Last updated
- 2025-03-14
Source: ClinicalTrials.gov record NCT06876727. Inclusion in this directory is not an endorsement.